Oral anticoagulation on patients with atrial fibrillation: are we doing a good job?

INTRODUCTION: Atrial fibrillation (AF) is one of the major causes of stroke and cardiovascular morbidity in the world [1]. Oral anticoagulation (OAC) with vitamin K antagonists (VKAs) or non-VKA oral anticoagulants (NOACs) reduces the risk of such events in AF patients [1–3]. Our aim was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Joana C. F., Aguiar, João, Ferreira, Margarida Paixão, Calixto, Rita, Cesário, Vera, Vaz, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Abstract 86
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480825/
http://dx.doi.org/10.1080/07853890.2021.1896844

Ejemplares similares

Ejemplares similares